Fedrilate

Clinical data
Trade names	Tussefan
ATC code	R05DB14 (WHO)
Identifiers
IUPAC name 4-morpholin-4-ylbutan-2-yl 4-phenyloxane-4-carboxylate
CAS Number	23271-74-1
PubChem CID	31796
ChemSpider	29485 Y
UNII	NT86R8M7J5
KEGG	D07389 Y
ChEMBL	ChEMBL2104591
ECHA InfoCard	100.041.390
Chemical and physical data
Formula	C20H29NO4
Molar mass	347.455 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OC(CCN1CCOCC1)C)C3(c2ccccc2)CCOCC3
InChI InChI=1S/C20H29NO4/c1-17(7-10-21-11-15-24-16-12-21)25-19(22)20(8-13-23-14-9-20)18-5-3-2-4-6-18/h2-6,17H,7-16H2,1H3 Y Key:RDEOYUSTRWNWLX-UHFFFAOYSA-N Y
(verify)

Fedrilate is a centrally acting cough suppressant. It was patented as a mucolytic by UCB in 1971, but was never brought to market in the US.^[1] In the Netherlands, it has been marketed as Tussefan and in combination with guaifenesin as Tussefan expectorans.^[2]